Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Smith

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
AIDS (London, England)|August 23, 2018
Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIVJeremiah D Momper, Brookie M Best, Jiajia Wang, et al.
Aesthetic Surgery Journal|January 17, 2025
Nipple Position and Clinical Outcomes Following Nipple-Sparing Mastectomy: An Examination of Prepectoral and Subpectoral Implant-Based Reconstruction Utilizing 3D ImagingCarrie S Stern, Francis D Graziano, Donovan R White, et al.
Molecular Cancer Therapeutics|October 28, 2010
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeuticsAndrea D Basso, Ming Liu, Chaoyang Dai, et al.
Pharmacology Research & Perspectives|October 4, 2017
An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy modelXiaoyan Zhou, Ji Zhang, Robin Haimbach, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)William T Shearer, Jaime G DeVille, Pearl M Samson, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Fosamprenavir with Ritonavir Pharmacokinetics during PregnancyAhizechukwu C Eke, Jiajia Wang, Khadija Amin, et al.
Frontiers in Immunology|February 7, 2018
B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus VaccineAdriana Weinberg, Jane Lindsey, Ronald Bosch, et al.
Journal of the American College of Cardiology|March 15, 2018
4-Step Protocol for Disparities in STEMI Care and Outcomes in WomenChetan P Huded, Michael Johnson, Kathleen Kravitz, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Scientific Reports|May 6, 2026
Establishing the first Afro-Caribbean breast cancer cell lines reveals ECM pathway enrichment and distinctive drug sensitivitiesShannique Clarke, Isabella Allen, Jovanka Ravix, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
AIDS (London, England)|August 23, 2018
Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIVJeremiah D Momper, Brookie M Best, Jiajia Wang, et al.
Aesthetic Surgery Journal|January 17, 2025
Nipple Position and Clinical Outcomes Following Nipple-Sparing Mastectomy: An Examination of Prepectoral and Subpectoral Implant-Based Reconstruction Utilizing 3D ImagingCarrie S Stern, Francis D Graziano, Donovan R White, et al.
Molecular Cancer Therapeutics|October 28, 2010
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeuticsAndrea D Basso, Ming Liu, Chaoyang Dai, et al.
Pharmacology Research & Perspectives|October 4, 2017
An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy modelXiaoyan Zhou, Ji Zhang, Robin Haimbach, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)William T Shearer, Jaime G DeVille, Pearl M Samson, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Fosamprenavir with Ritonavir Pharmacokinetics during PregnancyAhizechukwu C Eke, Jiajia Wang, Khadija Amin, et al.
Frontiers in Immunology|February 7, 2018
B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus VaccineAdriana Weinberg, Jane Lindsey, Ronald Bosch, et al.
Journal of the American College of Cardiology|March 15, 2018
4-Step Protocol for Disparities in STEMI Care and Outcomes in WomenChetan P Huded, Michael Johnson, Kathleen Kravitz, et al.
The Lancet. Infectious Diseases|February 4, 2011
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial, Abdel Babiker, Hannah Castro nee Green, et al.
Scientific Reports|May 6, 2026
Establishing the first Afro-Caribbean breast cancer cell lines reveals ECM pathway enrichment and distinctive drug sensitivitiesShannique Clarke, Isabella Allen, Jovanka Ravix, et al.
Pageof 34